Updated NTM pulmonary disease estimates in U.S. Medicare beneficiaries revealed rising incidence, demographic disparities, and associated comorbidities.
Mycobacterium avium complex (MAC) is group of organisms causing a bacterial infection that leads to lung disease. MAC is noncontagious and made up of nontuberculous mycobacteria (NTM), which are ...
in adult patients with nontuberculous mycobacterial (NTM) pulmonary disease. The therapy showed an improvement in at least 50 ...
The mucus is a common symptom in chronic lung diseases such as COPD ( chronic bronchitis and emphysema), cystic fibrosis, bronchiectasis, NTM lung disease, or asthma. Besides ailments related to lungs ...
In a study of 66 adult patients with nontuberculous mycobacteria pulmonary disease (NTM-PD) caused by mycobacterium abscessus ...
USA-based Paratek Pharmaceuticals has released positive top-line data from a Phase IIb trial evaluating its oral antibiotic ...
First randomized placebo-controlled trial in NTM abscessusSymptom-based endpoints showed favorable improvement in frequency and severity of the most common symptomsMicrobiologic endpoints showed ...
In a report released today, Roy Buchanan from JMP Securities reiterated a Buy rating on AN2 Therapeutics, Inc. (ANTX – Research Report), with a ...
Paratek Pharma announces positive top-line data from phase 2b study of oral omadacycline in NTM abscessus pulmonary disease: Boston Monday, November 11, 2024, 18:00 Hrs [IST] Para ...